Brickell Biotech

-$0.027 (-3.18%) Today
+$0.047 (+5.71%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BBI and other stocks, options, and ETFs commission-free!

About BBI

Brickell Biotech, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis.

CEO
Robert B. Brown
Employees
13
Headquarters
Boulder, Colorado
Founded
2009

BBI Key Statistics

Market Cap
59.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
703.29K
High Today
$0.8699
Low Today
$0.8101
Open Price
$0.86
Volume
865.41K
52 Week High
$2.61
52 Week Low
$0.466

BBI Earnings

-$2.44
-$1.63
-$0.81
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.11 per share
Actual
-$0.15 per share
Replay Earnings Call

You May Also Like

NESR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure